Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis

Future treatments of multiple sclerosis (MS), a chronic autoimmune neurodegenerative disease of the central nervous system (CNS), aim for simultaneous early targeting of peripheral immune function and neuroinflammation. Sphingosine-1-phosphate (S1P) receptor modulators are among the most promising d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cells
Main Authors: Musella, Alessandra, Gentile, Antonietta, Guadalupi, Livia, Rizzo, Francesca Romana, De Vito, Francesca, Fresegna, Diego, Bruno, Antonio, Dolcetti, Ettore, Vanni, Valentina, Vitiello, Laura, Bullitta, Silvia, Sanna, Krizia, Caioli, Silvia, Balletta, Sara, Nencini, Monica, Buttari, Fabio, Stampanoni Bassi, Mario, Centonze, Diego, Mandolesi, Georgia
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7291065/
https://ncbi.nlm.nih.gov/pubmed/32455907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9051290
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados